Open AccessERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial
Author(s) -
J. E. Bauman,
M. C. Austin,
Rachel O Schmidt,
B. F. Kurland,
A. Vaezi,
D. Neil Hayes,
E. Mendez,
U. Parvathaneni,
X. Chai,
S. Sampath,
R. G. Martins
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/vnx9-5k35
Subject(s) - head and neck cancer , medicine , oncology , ercc1 , head and neck , biomarker , randomized controlled trial , cancer , surgery , biology , gene , nucleotide excision repair , biochemistry , dna repair